Oxford Biomedica (OXB)

Down
Share Price:
487.00p
Market Cap:
£589.49m
Change Today:
-0.50p
Sector:
Pharma and Biotech
Select: Overview | Profit And Loss | Balance Sheet | Cash Flow | Key Financials

Dividend Data

  31-Dec-2531-Dec-2431-Dec-2331-Dec-2231-Dec-21
Interim Dividendn/an/an/an/an/a
Final Dividendn/an/an/an/an/a
Total Dividendn/an/an/an/an/a

Fundamentals - based on IFRS

  £ (Millions) £ (Millions) £ (Millions) £ (Millions) £ (Millions)
Income Statement 31-Dec-25 31-Dec-24 31-Dec-23 31-Dec-22 31-Dec-21
Continuing Operations          
Revenue 168.74 128.80 89.54 139.99 142.80
Operating Profit/(Loss) (22.48) (39.38) (184.17) (30.22) 20.77
Net Interest n/a n/a (14.17) (15.76) (0.89)
Profit Before Tax (31.94) (47.27) (188.53) (45.98) 19.88
Profit After Tax (30.64) (48.61) (184.16) (45.16) 19.01
Discontinued Operations          
Profit After Tax n/a n/a n/a n/a n/a
PROFIT FOR THE PERIOD (30.64) (48.61) (184.16) (45.16) 19.01
Attributable to:          
Equity Holders of Parent Company (30.13) (43.19) (157.49) (39.16) 19.01
Minority Interests (0.52) (5.42) (26.67) (6.00) n/a
           
Total Dividend Paid cn/a cn/a cn/a cn/a cn/a
Retained Profit/(Loss) for the Financial Year cn/a cn/a cn/a cn/a cn/a
           
Continuing EPS          
Earnings per Share - Basic (26.92p) (41.75p) (163.11p) (41.29p) 22.77p
Earnings per Share - Diluted (26.92p) (41.75p) (163.11p) (41.29p) 22.20p
Earnings per Share - Adjusted (26.92p) (41.75p) (163.11p) (41.29p) 22.77p
Continuing and Discontinued EPS          
Earnings per Share - Basic (26.92p) (41.75p) (163.11p) (41.29p) 22.77p
Earnings per Share - Diluted (26.92p) (41.75p) (163.11p) (41.29p) 22.20p
Earnings per Share - Adjusted (26.92p) (41.75p) (163.11p) (41.29p) 22.77p
           
Dividend per Share n/a n/a n/a n/a n/a
  £ (Millions) £ (Millions) £ (Millions) £ (Millions) £ (Millions)
Balance Sheet 31-Dec-25 31-Dec-24 31-Dec-23 31-Dec-22 31-Dec-21
Assets          
Non-Current Assets          
Property, Plant & Equipment 107.63 64.30 75.69 133.78 69.73
Intangible Assets 25.17 29.22 30.98 105.89 0.05
Investment Properties n/a n/a n/a n/a n/a
Investments n/a n/a n/a n/a n/a
Other Financial Assets n/a n/a n/a n/a n/a
Other Non-Current Assets 7.28 4.93 4.34 5.01 3.60
  140.07 98.45 111.01 244.68 73.39
Current Assets          
Inventories 17.33 13.57 12.87 12.62 9.52
Trade & Other Receivables 71.27 58.97 24.74 61.59 44.75
Cash at Bank & in Hand 96.88 60.65 103.72 141.28 108.94
Current Asset Investments n/a n/a n/a n/a n/a
Other Current Assets 0.17 n/a n/a n/a 0.63
  185.65 133.19 141.33 215.50 163.84
           
Other Assets n/a n/a n/a n/a n/a
Total Assets 325.72 231.64 252.34 460.18 237.23
           
Liabilities          
Current Liabilities          
Borrowings 6.06 4.42 3.65 3.29 0.85
Other Current Liabilities 78.16 53.90 40.66 56.37 32.45
  84.22 58.32 44.31 59.66 33.31
           
Net Current Assets cn/a cn/a cn/a cn/a cn/a
           
Non-Current Liabilities          
Borrowings 142.07 104.34 107.80 110.99 8.49
Provisions 7.39 7.42 8.55 14.01 6.24
Other Non-Current Liabilities 0.69 1.07 13.84 39.33 1.85
  150.15 112.83 130.19 164.32 16.58
           
Other Liabilities n/a n/a n/a n/a n/a
Total Liabilities 234.37 171.16 174.51 223.99 49.89
           
Net Assets 91.35 60.49 77.83 236.19 187.34
           
Capital & Reserves          
Share Capital 60.38 52.98 48.40 48.13 43.09
Share Premium Account 445.85 394.86 380.33 379.95 307.77
Other Reserves 7.47 8.71 (1.81) (24.89) 2.29
Retained Earnings (422.35) (399.50) (352.92) (198.54) (165.81)
Shareholders Funds 91.35 57.05 74.01 204.65 187.34
           
Minority Interests/Other Equity n/a 3.44 3.83 31.54 n/a
Total Equity 91.35 60.49 77.83 236.19 187.34
Cash Flow 31-Dec-25 31-Dec-24 31-Dec-23 31-Dec-22 31-Dec-21
Net Cash Flow From Operating Activities 0.51 (50.67) (28.52) (12.62) 25.45
Returns On Investment & Servicing of Finance fn/a fn/a fn/a fn/a fn/a
Taxation Paid fn/a fn/a fn/a fn/a fn/a
Net Cash Flow from Investing Activities (5.72) 5.63 2.81 (56.46) (9.46)
Acquisitions & Disposals gn/a gn/a gn/a gn/a gn/a
Dividends Paid fn/a fn/a fn/a fn/a fn/a
Management of Liquid Resources cn/a cn/a cn/a cn/a cn/a
Net Cash Flow from Financing Activities 42.26 2.91 (12.70) 98.62 46.21
Net Increase/Decrease In Cash 37.04 (42.13) (38.41) 29.55 62.20
Ratios - based on IFRS 31-Dec-25 31-Dec-24 31-Dec-23 31-Dec-22 31-Dec-21
Continuing Operations          
PE Ratio - Adjusted n/a n/a n/a n/a 54.0
PEG - Adjusted n/a n/a n/a n/a n/a
Earnings per Share Growth - Adjusted n/a n/a n/a n/a n/a
Dividend Cover n/a n/a n/a n/a n/a
Revenue per Share 139.40p 106.41p 92.73p 115.65p 117.97p
Pre-Tax Profit per Share (26.38p) (39.05p) (195.25p) (37.98p) 16.42p
Operating Margin (13.32%) (30.57%) (205.69%) (21.59%) 14.54%
Return on Capital Employed (14.41%) (32.05%) (104.49%) (11.69%) 10.24%
Continuing & Discontinued Operations          
PE Ratio - Adjusted n/a n/a n/a n/a 54.0
PEG - Adjusted n/a n/a n/a n/a n/a
Earnings per Share Growth - Adjusted n/a n/a n/a n/a n/a
Dividend Cover n/a n/a n/a n/a n/a
           
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0%
Dividend per Share Growth n/a n/a n/a n/a n/a
Operating Cash Flow per Share 0.42p (41.86p) (29.53p) (10.42p) 21.03p
Cash Incr/Decr per Share 30.60p (34.80p) (39.78p) 24.41p 51.39p
Net Asset Value per Share (exc. Intangibles) 54.67p 25.83p 48.52p 107.65p 154.72p
Net Gearing 56.10% 84.34% 10.46% -13.20% -53.17%

Key

* GAAP

a. Includes discontinued activities

b. Including assets due in more than one year

c. Not disclosed under IFRS

d. Total fixed assets

e. Includes borrowings

f. Included in cash flow from operating activities under IFRS

g. Included in net cash from investing activities under IFRS

h. Pre-tax

i. Capital expenditure

j. Based on operating cash flow before tax

k. Issue of ordinary shares

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: Forecast figures based on normalised accounts.